Results 131 to 140 of about 3,331,814 (239)

Theoretical design for covering Engeletin with functionalized nanostructure-lipid carriers as neuroprotective agents against Huntington's disease via the nasal-brain route. [PDF]

Front Pharmacol, 2023
Smriti, Singla M, Gupta S, Porwal O, Nasser Binjawhar D, Sayed AA, Mittal P, El-Demerdash FM, Algahtani M, Singh SK, Dua K, Gupta G, Bawa P, Altyar AE, Abdel-Daim MM.   +14 more
europepmc   +1 more source

Potential neuroprotective agent from botanical extract: An experience of using Verbena officinalis against β-amyloid peptide neurotoxicity [PDF]

, 2006
SW Lai, Fujun Yu, WH Yuen, Sy Zee, Kwok‐Fai So, Raymond Chuen‐Chung Chang   +5 more
openalex  

Neuroprotective Agents With Reperfusion Therapies in Ischemic Stroke: Evidence From Recent Randomized Trials. [PDF]

Cureus
Wesley MJ, Gundala Raja H, Shahid MS, Akbar A, Jeyakumar D, Veluchamy E, Sivakumar M, Tahir F, Jiménez Royg D, Pant R, Rehman A.   +10 more
europepmc   +1 more source

The Discovery of Novel PGK1 Activators as Apoptotic Inhibiting and Neuroprotective Agents. [PDF]

Front Pharmacol, 2022
Qiang SJ, Shi YQ, Wu TY, Wang JQ, Chen XL, Su J, Chen XP, Li JZ, Chen ZS.   +8 more
europepmc   +1 more source

Which Neuroprotective Agents are Ready for Bench to Bedside Translation in the Newborn Infant?

, 2012
Nicola J. Robertson, Sidhartha Tan, Floris Groenendaal, Frank van Bel, Sandra E. Juul, Laura Bennet, Matthew Derrick, Stephen A. Back, Raul Chavez‐Valdez, Frances J. Northington, Alistair J. Gunn, Carina Mallard   +11 more
openalex   +1 more source

Hesperidin as a Neuroprotective Agent: A Review of Animal and Clinical Evidence [PDF]

, 2019
Marziyeh Hajialyani, Mohammad Hosein Farzaei, Javier Echeverría, Seyed Mohammad Nabavi, Eugenio Uriarte, Eduardo Sobarzo‐Sánchez   +5 more
openalex   +1 more source

Computer-aided discovery of triazolothiadiazoles as DYRK1A-targeted neuroprotective agents. [PDF]

RSC Med Chem
Si X, Wang Y, Qiu N, Qian C, Yang B, Jin H, Wang H, Zhang X, Xia J.   +8 more
europepmc   +1 more source

Comparing the efficacy in reducing brain injury of different neuroprotective agents following neonatal hypoxia-ischemia in newborn rats: a multi-drug randomized controlled screening trial. [PDF]

Sci Rep, 2023
Sabir H, Maes E, Zweyer M, Schleehuber Y, Imam FB, Silverman J, White Y, Pang R, Pasca AM, Robertson NJ, Maltepe E, Bernis ME.   +11 more
europepmc   +1 more source

Why Most Acute Stroke Studies Are Positive in Animals but Not in Patients: A Systematic Comparison of Preclinical, Early Phase, and Phase 3 Clinical Trials of Neuroprotective Agents [PDF]

, 2019
Antje Schmidt‐Pogoda, Nadine Bonberg, Mailin Hannah Marie Koecke, Jan‐Kolja Strecker, Jürgen Wellmann, Nils Martin Bruckmann, Carolin Beuker, Wolf‐Rüdiger Schäbitz, Sven G. Meuth, Heinz Wiendl, Heike Minnerup, Jens Minnerup   +11 more
openalex   +1 more source

A new taxonomy of neuroprotective agents for stroke appropriate for the reperfusion era. [PDF]

Front Neurol
Bahr-Hosseini M, Saver JL.
europepmc   +1 more source